• Organizations: Sun Pharma
Sun Pharma to buy Organon in $11.75B all-cash deal
Business

Sun Pharma to buy Organon in $11.75B all-cash deal

Closing in early 2027, the acquisition will position the Indian pharma company as a leader in the global biosimilar, established brands / branded generic spaces.
Cequa's Onset of Action Trial demonstrates rapid ocular surface benefits
Research

Cequa's Onset of Action Trial demonstrates rapid ocular surface benefits

Recent data on the FDA-approved, preservative-free eye drop builds on supporting clinical findings—this time for DED patients preparing for refractive-cataract surgery.
Sun Pharma reports positive phase 4 efficacy data on CEQUA after Restasis for DED
Pipeline

Sun Pharma reports positive phase 4 efficacy data on CEQUA after Restasis for DED

Latest findings among patients switching from Restasis indicate significant improvements in total corneal staining and visual acuity.
Phase 4 data on Cequa indicates significant DED improvements
Products

Phase 4 data on Cequa indicates significant DED improvements

New efficacy findings are the first in a series examining the FDA-approved formulation for chronic dry eye.